Quick10K

⚲

Resolute Oncology

Filings

10-Q	2021-03-31	Filed 2021-05-06
10-K	2020-12-31	Filed 2021-03-01
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-01
10-K	2019-12-31	Filed 2020-02-28
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-08
10-K	2018-12-31	Filed 2019-02-26
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-09
10-K	2017-12-31	Filed 2018-02-26
10-Q	2017-09-30	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-10
10-K	2016-12-31	Filed 2017-02-27
10-Q	2016-09-30	Filed 2016-11-09
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-02-25
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-06
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-02-26
10-Q	2014-09-30	Filed 2014-11-05
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-06
10-K	2013-12-31	Filed 2014-02-27
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-07
10-Q	2013-03-31	Filed 2013-05-08
10-K	2012-12-31	Filed 2013-02-27
10-Q	2012-09-30	Filed 2012-11-08
10-Q	2012-06-30	Filed 2012-08-08
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-02-28
10-Q	2011-09-30	Filed 2011-11-08
10-Q	2011-06-30	Filed 2011-08-09
10-Q	2011-03-31	Filed 2011-05-12
10-K	2010-12-31	Filed 2011-03-17
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-08-16
10-Q	2010-03-31	Filed 2010-05-17

Reports

8-K	2020-11-04
8-K	2020-08-05
8-K	2020-05-13
8-K	2020-04-29
8-K	2020-02-11
8-K	2019-11-06
8-K	2019-10-01
8-K	2019-08-07
8-K	2019-05-16
8-K	2019-05-07
8-K	2019-02-07
8-K	2018-11-06
8-K	2018-08-07
8-K	2018-05-16
8-K	2018-05-08
8-K	2018-02-07

Resolute Oncology Financials

PRI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	114	154	136	156	108	186	112	203	118	147	149	158	151	165	193	180	154	161	152	176	213	195	212	186	154	177	280	191	159	225	262	280	245	238
Accounts Receivable
Inventory
PP&E							96				113				92				101				94				99				112
Assets	10,170	10,008	9,999	10,074	9,951	10,434	10,338	10,433	10,005	10,200	10,330	10,388	10,594	10,743	10,738	10,724	10,781	10,563	10,612	11,013	11,205	11,369	11,439	11,670	11,945	12,207	12,461	12,493	12,497	12,708	12,595	13,077	13,318	13,452
Accounts Payable
Long-Term Debt							375
Liabilities	8,623	8,436	8,576	8,687	8,674	9,097	9,062	9,125	8,859	9,004	9,108	9,135	9,291	9,448	9,493	9,485	9,584	9,416	9,466	9,840	9,997	10,148	10,218	10,423	10,676	10,926	11,042	11,066	11,096	11,264	11,134	11,555	11,732	11,844
Stockholders' Equity	1,547	1,572	1,423	1,387	1,277	1,337	1,275	1,308	1,146	1,196										1,173	1,207	1,221	1,221	1,246	1,269	1,281	1,419	1,427	1,401	1,443	1,462	1,521	1,586	1,608


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	275	276	276	287	311	299	305	308	312	319	327	324	331	339	345	345	351	356	354	363	379	384	394	405	414	427	443	460	468	485	487	495	505	521
Cost of Revenue
Gross Profit
R&D
SG&A
Tax	24	23	22	22	26	25	21	21	24	23	20	23	26	22	24	23	28	26	24	25	33	30	30	23	33	34	-60	17	27	26	21	23	30	29
Net Income	44	41	41	42	47	46	40	39	43	43	37	45	57	42	45	43	49	49	48	45	59	58	57	52	63	67	168	66	87	85	87	79	97	96


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		18	80	-16	29	95	13	64	-12	38	97	38	33	62	-19	66	19	56	118	35	69	61		53	67	90	179	46		121		66	119	136
Cash Investing		22	104	32	95	-72	12	35	95	-4	-90	-4	-13	-10	116	-27	33	32	-98	48	17	-29		-34	-45	-1	-49	-72		-10		25	-82	-58
Cash Financing		-2	-202	-2	-164	53	-98	-9	-167	-5	-5	-23	-28	-37	-88	-50	-79	-79	-28	-61	-48	-49		-45	-54	-67	-27	-63		-45		-75	-72	-85